Life sciences dealmaker and IP licensing lawyer Adam Golden is leaving Hogan Lovells to join Freshfields Bruckhaus Deringer, a firm that has made a slew of flashy hires in the U.S. over the past 18 months.
Golden will head Freshfields’ U.S. life sciences practice after representing clients such as Novartis AG, Gilead Sciences Inc., and Celgene Corp. He handles license and collaboration deals, M&A, financings, and commercial transactions.
“The firm has really made significant strides in the U.S.,” Golden said of Freshfields. “I see what’s happening and the types of transactions, antitrust matters, litigation and other matters the firm is ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.